'Drug of Monetization:' How Profits Can Accelerate GOOGL Innovation

Alphabet (GOOGL) has experienced a surge in its stock price after lagging through most of 2025. Wedbush's Scott Devitt adds that Alphabet's backdrop has improved "significantly" from a consumer sentiment and technological standpoint but won't be surprised to see a cooldown in price action. He talks about how the company has become "addicted to the drug of monetization," which can be used as a way to fuel future innovation and profits. Tom White offers a pair of example options trades for the Mag 7 giant.

Morning Trade Live

10 Oct 2025

SHARE

Schwab Network's Newsletters

Daily insights for every investor